Report #2824248

Received Feb 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 68 yrs
State: PA
Recovered: Recovered
Vaccinated: Jan 13, 2025
Onset: Jan 14, 2025
Days to onset: 1
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
FLU3	INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE)	SANOFI PASTEUR	N/A	388490	IM / LA
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	N/A	255t2	IM / LA

Symptoms (3)

Injection site reactionRashRash erythematous

Symptom narrative

Patient expresses that they noticed a large red rash at the site of injection the day following immunization. Over the course of the next few days, the rash spread from the injection site to a full body rash. The patient denies any other symptoms such as difficulty breathing or painful rash sites. The patient returned to the pharmacy on January 27th, 2025 to discuss this event and says the rash was gone when they returned. The patient claims they experience similar full body rashes when exposed to respiratory illnesses. The patient did not express that they treated the rash with any medication or seek medical treatment.

Allergies

penicillin